RON BENTSUR - 12 Jan 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
12 Jan 2023
Transactions value $
$0
Form type
4
Filing time
13 Jan 2023, 16:04:45 UTC
Previous filing
30 Nov 2022
Next filing
16 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Award $0 +210,000 +6.96% $0.000000 3,225,459 12 Jan 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units will vest according to the following schedule: one-third on each of 01/12/2024, 01/12/2025, and 01/12/2026.
F2 Includes 96,759 shares of restricted stock and 330,000 restricted stock units.